메뉴 건너뛰기




Volumn 49, Issue 1, 2012, Pages 17-28

Flow cytometry in clinical pathology

Author keywords

[No Author keywords available]

Indexed keywords

7 AMINODACTINOMYCIN; ALLOPHYCOCYANIN; FLUORESCEIN ISOTHIOCYANATE; FLUOROCHROME; MONOCLONAL ANTIBODY; PHYCOERYTHRIN; PROPIDIUM IODIDE;

EID: 84855948075     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2011.011128     Document Type: Article
Times cited : (36)

References (49)
  • 1
    • 0036792398 scopus 로고    scopus 로고
    • The history and future of the uorescence activated cell sorter and ow cytometry: a view from Stanford
    • Herzenberg LA, Parks D, Sahaf B, Perez O, Roederer M, Herzenberg LA. The history and future of the uorescence activated cell sorter and ow cytometry: a view from Stanford. Clin Chem 2002;48:1819-27
    • (2002) Clin Chem , vol.48 , pp. 1819-1827
    • Herzenberg, L.A.1    Parks, D.2    Sahaf, B.3    Perez, O.4    Roederer, M.5    Herzenberg, L.A.6
  • 2
    • 1542514871 scopus 로고    scopus 로고
    • Twenty-ve years of clinical ow cytometry: AIDS accelerated global instrument distribution
    • Mandy FF. Twenty-ve years of clinical ow cytometry: AIDS accelerated global instrument distribution. Cytometry 2004;58A: 55-6
    • (2004) Cytometry , vol.58 A , pp. 55-56
    • Mandy, F.F.1
  • 3
    • 0037234069 scopus 로고    scopus 로고
    • Beyond six colors: a new era in ow cytometry
    • De Rosa SC, Brenchley JM, Roederer M. Beyond six colors: a new era in ow cytometry. Nat Med 2003;9:112-7
    • (2003) Nat Med , vol.9 , pp. 112-117
    • De Rosa, S.C.1    Brenchley, J.M.2    Roederer, M.3
  • 5
    • 0033884049 scopus 로고    scopus 로고
    • Flow cytometry: principles and clinical applications in hematology
    • Brown M, Wittwer C. Flow cytometry: principles and clinical applications in hematology. Clin Chem 2000;46:1221-9
    • (2000) Clin Chem , vol.46 , pp. 1221-1229
    • Brown, M.1    Wittwer, C.2
  • 6
    • 33845531087 scopus 로고    scopus 로고
    • Del Vecchio L Flow cytometry analysis of acute promyelocytic leukemia: the power of 'surface hematology'
    • Di Noto R, Mirabelli P, Del Vecchio L. Flow cytometry analysis of acute promyelocytic leukemia: the power of 'surface hematology'. Leukemia 2007;21:4-8
    • (2007) Leukemia , vol.21 , pp. 4-8
    • Di Noto, R.1    Mirabelli, P.2
  • 7
    • 24744447579 scopus 로고    scopus 로고
    • CD molecules2005 human cell differentiation molecules
    • Zola H, Swart B, Nicholson I, et al. CD molecules 2005: human cell differentiation molecules. Blood 2005;106:3123-6
    • (2005) Blood , vol.106 , pp. 3123-3126
    • Zola, H.1    Swart, B.2    Nicholson, I.3
  • 8
    • 41349113572 scopus 로고    scopus 로고
    • FMC7 is an epitope of CD20
    • Deans JP, Polyak MJ. FMC7 is an epitope of CD20. Blood 2008;111:2492
    • (2008) Blood , vol.111 , pp. 2492
    • Deans, J.P.1    Polyak, M.J.2
  • 9
    • 0026556554 scopus 로고
    • Dead cell discrimination with 7-amino-actinomycin D in combination with dual colour immunouorescence in single laser ow cytometry
    • Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV. Dead cell discrimination with 7-amino-actinomycin D in combination with dual colour immunouorescence in single laser ow cytometry. Cytometry 1992;13:204-8
    • (1992) Cytometry , vol.13 , pp. 204-208
    • Schmid, I.1    Krall, W.J.2    Uittenbogaart, C.H.3    Braun, J.4    Giorgi, J.V.5
  • 10
    • 0032768827 scopus 로고    scopus 로고
    • Quality control of ow cytometric immunophenotyping of haematological malignancies
    • Gratama JW, Bolhuis RLH, Van't Veer MB. Quality control of ow cytometric immunophenotyping of haematological malignancies. Clin Lab Haem 1999;21:155-60
    • (1999) Clin Lab Haem , vol.21 , pp. 155-160
    • Gratama, J.W.1    Bolhuis, R.L.H.2    Van't Veer, M.3
  • 11
    • 0034699436 scopus 로고    scopus 로고
    • Validation and quality control of immunophenotyping in clinical ow cytometry
    • Owens MA, Vall HG, Hurley AA, Wormsley SB. Validation and quality control of immunophenotyping in clinical ow cytometry. J Immunol Methods 2000;243:33-50
    • (2000) J Immunol Methods , vol.243 , pp. 33-50
    • Owens, M.A.1    Vall, H.G.2    Hurley, A.A.3    Wormsley, S.B.4
  • 12
    • 0032522567 scopus 로고    scopus 로고
    • Single platform ow cytometric absolute CD34{thorn} cell counts based on the ISHAGE guidelines
    • Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform ow cytometric absolute CD34{thorn} cell counts based on the ISHAGE guidelines. Cytometry 1998;34:61-70
    • (1998) Cytometry , vol.34 , pp. 61-70
    • Keeney, M.1    Chin-Yee, I.2    Weir, K.3    Popma, J.4    Nayar, R.5    Sutherland, D.R.6
  • 14
    • 0035503984 scopus 로고    scopus 로고
    • Spectral compensation for ow cytometry: visualization artefacts, limitations, and caveats
    • Roederer M. Spectral compensation for ow cytometry: visualization artefacts, limitations, and caveats. Cytometry 2001;45:194-205
    • (2001) Cytometry , vol.45 , pp. 194-205
    • Roederer, M.1
  • 15
    • 34447527235 scopus 로고    scopus 로고
    • Modern ow cytometry: a practical approach
    • Tung JW, Heydari K, Tirouvanziam R, et al. Modern ow cytometry: a practical approach. Clin Lab Med 2007;27:453-68
    • (2007) Clin Lab Med , vol.27 , pp. 453-468
    • Tung, J.W.1    Heydari, K.2    Tirouvanziam, R.3
  • 16
  • 19
    • 32444433947 scopus 로고    scopus 로고
    • Quantitative ow cytometry in the clinical laboratory
    • Maher KJ, Fletcher MA. Quantitative ow cytometry in the clinical laboratory. Clin Appl Immunol Rev 2005;5:353-72
    • (2005) Clin Appl Immunol Rev , vol.5 , pp. 353-372
    • Maher, K.J.1    Fletcher, M.A.2
  • 20
    • 0036008654 scopus 로고    scopus 로고
    • Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders
    • Bain BJ, Barnett D, Linch D, Matutes E, Reilly JT. Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haem 2002;24:1-13
    • (2002) Clin Lab Haem , vol.24 , pp. 1-13
    • Bain, B.J.1    Barnett, D.2    Linch, D.3    Matutes, E.4    Reilly, J.T.5
  • 21
    • 1842535086 scopus 로고    scopus 로고
    • Peripheral Blood CD34+ cell counts allow improved management of peripheral blood stem cell collections
    • Gibbs G, Bolam S. Peripheral Blood CD34+ cell counts allow improved management of peripheral blood stem cell collections. Br J Biomed Sci 2004;61:35-7
    • (2004) Br J Biomed Sci , vol.61 , pp. 35-37
    • Gibbs, G.1    Bolam, S.2
  • 22
    • 0036092789 scopus 로고    scopus 로고
    • Neutrophil CD64 expression: distinguishing acute inammatory autoimmune disease from systemic infections
    • Allen E, Bakke AC, Purtzer MZ, Deodhar A. Neutrophil CD64 expression: distinguishing acute inammatory autoimmune disease from systemic infections. Ann Rheum Dis 2002;61:522-5
    • (2002) Ann Rheum Dis , vol.61 , pp. 522-525
    • Allen, E.1    Bakke, A.C.2    Purtzer, M.Z.3    Deodhar, A.4
  • 23
    • 0344667634 scopus 로고    scopus 로고
    • Multicenter clinical experience with ow cytometric method for fetomaternal hemorrhage detection
    • Chen JC, Davis BH, Wood B, Warzynski MJ. Multicenter clinical experience with ow cytometric method for fetomaternal hemorrhage detection. Cytometry 2002;50:285-90
    • (2002) Cytometry , vol.50 , pp. 285-290
    • Chen, J.C.1    Davis, B.H.2    Wood, B.3    Warzynski, M.J.4
  • 24
    • 0037355339 scopus 로고    scopus 로고
    • Prognostic signicance of CD38 and CD20 expression as assessed by quantitative ow cytometry in chronic lymphocytic leukaemia
    • Hsi ED, Kopecky KJ, Appelbaum FR, et al. Prognostic signicance of CD38 and CD20 expression as assessed by quantitative ow cytometry in chronic lymphocytic leukaemia. Br J Haematol 2003;120:1017-25
    • (2003) Br J Haematol , vol.120 , pp. 1017-1025
    • Hsi, E.D.1    Kopecky, K.J.2    Appelbaum, F.R.3
  • 25
    • 33748512177 scopus 로고    scopus 로고
    • Quantitative ow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble uorochrome
    • Kay S, Herishanu Y, Pick M, et al. Quantitative ow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble uorochrome. Cytometry B 2006;70B:218-26
    • (2006) Cytometry B , vol.70 B , pp. 218-226
    • Kay, S.1    Herishanu, Y.2    Pick, M.3
  • 26
    • 34447517121 scopus 로고    scopus 로고
    • Quality control in clinical ow cytometry
    • Oldaker TA. Quality control in clinical ow cytometry. Clin Lab Med 2007;27:671-85
    • (2007) Clin Lab Med , vol.27 , pp. 671-685
    • Oldaker, T.A.1
  • 27
    • 34447507803 scopus 로고    scopus 로고
    • More than just quality control
    • Carey JL, Oldaker TA. More than just quality control. Clin Lab Med 2007;27:687-707
    • (2007) Clin Lab Med , vol.27 , pp. 687-707
    • Carey, J.L.1    Oldaker, T.A.2
  • 35
    • 0031466392 scopus 로고    scopus 로고
    • Denition of acute biphenotypic leukemia
    • Matutes E, Morilla R, Farahat N, et al. Denition of acute biphenotypic leukemia. Haematologica 1997;82:64-6
    • (1997) Haematologica , vol.82 , pp. 64-66
    • Matutes, E.1    Morilla, R.2    Farahat, N.3
  • 36
    • 0003866728 scopus 로고    scopus 로고
    • Primary and Secondary Immunodeciencies
    • eds. Endocrine Disorders (Section 12).18th edn. New Jersey: Merck & Co
    • Beers MH, Porter RS, eds. Endocrine Disorders (Section 12). Primary and Secondary Immunodeciencies. In: The Merck Manual of Diagnosis and Therapy. 18th edn. New Jersey: Merck & Co, 2006
    • (2006) The Merck Manual of Diagnosis and Therapy
    • Beers, M.H.1    Porter, R.S.2
  • 37
    • 0033397444 scopus 로고    scopus 로고
    • The use of ow cytometry to measure neutrophil function
    • van Eedena S, Kluta M, Walkerb B, et al. The use of ow cytometry to measure neutrophil function. J Imm Meth 1999;232:23-43
    • (1999) J Imm Meth , vol.232 , pp. 23-43
    • van Eedena, S.1    Kluta, M.2    Walkerb, B.3
  • 39
    • 22144497190 scopus 로고    scopus 로고
    • Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia
    • Chevalier P, Roland V, Mahe B, et al. Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia. Leuk Res 2005;29:103-7
    • (2005) Leuk Res , vol.29 , pp. 103-107
    • Chevalier, P.1    Roland, V.2    Mahe, B.3
  • 40
    • 31444453579 scopus 로고    scopus 로고
    • Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism
    • Mone AP, Cheney C, Banks AL, et al. Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism. Leukemia 2006;20:272-9
    • (2006) Leukemia , vol.20 , pp. 272-279
    • Mone, A.P.1    Cheney, C.2    Banks, A.L.3
  • 41
    • 2642547946 scopus 로고    scopus 로고
    • Minimal residual disease studies by ow cytometry in acute leukemia
    • Campana D, Coustan-Smith E. Minimal residual disease studies by ow cytometry in acute leukemia. Acta Haematol 2004;112:8-15
    • (2004) Acta Haematol , vol.112 , pp. 8-15
    • Campana, D.1    Coustan-Smith, E.2
  • 42
    • 0037555007 scopus 로고    scopus 로고
    • Guidelines for the estimation of fetomaternal haemorrhage
    • Austin E, Bates S, de Silva M, et al. Guidelines for the estimation of fetomaternal haemorrhage. Transfus Med 1999;9:87-92
    • (1999) Transfus Med , vol.9 , pp. 87-92
    • Austin, E.1    Bates, S.2    de Silva, M.3
  • 43
    • 0001107677 scopus 로고    scopus 로고
    • Guideline for the ow cytometric enumeration of CD34+ haematopoietic stem cells
    • Barnett D, Janossy G, Lubenko A, et al. Guideline for the ow cytometric enumeration of CD34+ haematopoietic stem cells. Clin Lab Haem 1999;21:301-8
    • (1999) Clin Lab Haem , vol.21 , pp. 301-308
    • Barnett, D.1    Janossy, G.2    Lubenko, A.3
  • 45
    • 84873067731 scopus 로고    scopus 로고
    • The management of paroxysmal nocturnal hemoglobinuria - recent advances in diagnosis and treatment, and new hope for patients
    • Schrezenmeier H, Höchsmann B. The management of paroxysmal nocturnal hemoglobinuria -recent advances in diagnosis and treatment, and new hope for patients. US Hematol 2009;2:74-80
    • (2009) US Hematol , vol.2 , pp. 74-80
    • Schrezenmeier, H.1    Höchsmann, B.2
  • 46
    • 0031959217 scopus 로고    scopus 로고
    • Rapid heterozygote detection in Glanzmann's thrombasthenia
    • Sharp WJ, Khanduri UD, Christie BS. Rapid heterozygote detection in Glanzmann's thrombasthenia. Br J Haematol 1998;101:66-9
    • (1998) Br J Haematol , vol.101 , pp. 66-69
    • Sharp, W.J.1    Khanduri, U.D.2    Christie, B.S.3
  • 47
    • 1542475297 scopus 로고    scopus 로고
    • Role of ow cytometry in the diagnostic evaluation of primary immunodeciency disease
    • O'Gorman M, Scholl P. Role of ow cytometry in the diagnostic evaluation of primary immunodeciency disease. Clin Appl Immunol Rev 2002;2:321-35
    • (2002) Clin Appl Immunol Rev , vol.2 , pp. 321-335
    • O'Gorman, M.1    Scholl, P.2
  • 48
    • 0032922549 scopus 로고    scopus 로고
    • A novel leukocyte adhesion deciency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1
    • Hogg N, Stewart MP, Scarth SL, et al. A novel leukocyte adhesion deciency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J Clin Invest 1999;103:97-106
    • (1999) J Clin Invest , vol.103 , pp. 97-106
    • Hogg, N.1    Stewart, M.P.2    Scarth, S.L.3
  • 49
    • 34447542504 scopus 로고    scopus 로고
    • Cellular image analysis and imaging by ow cytometry
    • Basiji D, Ortyn W, Liang L, et al. Cellular image analysis and imaging by ow cytometry. Clin Lab Med 2007;27:653-7
    • (2007) Clin Lab Med , vol.27 , pp. 653-657
    • Basiji, D.1    Ortyn, W.2    Liang, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.